Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RNA vaccines

Tuning the immune response to mRNA vaccines

A strategy to control translation of mRNA vaccines reveals cell type–specific contributions to immunity that may be harnessed to enhance vaccine efficacy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: microRNA platform for cell-specific mRNA silencing and limitations in translating to humans.
The alternative text for this image may have been generated using AI.

References

  1. Marks, A. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-026-03099-z (2026).

    Article  Google Scholar 

  2. Wang, J. et al. Nat. Biomed. Eng. 9, 201–214 (2025).

    Article  CAS  PubMed  Google Scholar 

  3. Rood, J. E. et al. Nat. Commun. 17, 1327 (2026).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hassett, K. J. et al. Mol. Ther. Nucleic Acids 35, 102083 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Buckley, M. et al. Mol. Ther. 33, 1105–1117 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhu, Y. et al. Nat. Biomed. Eng. 8, 544–560 (2024).

    Article  CAS  PubMed  Google Scholar 

  7. Alameh, M. G. et al. Immunity 54, 2877–2892.e7 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Di, J. et al. Pharm. Res. 39, 105–114 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tahtinen, S. et al. Nat. Immunol. 23, 532–542 (2022).

    Article  CAS  PubMed  Google Scholar 

  10. Parrett, B. J., Yamaoka, S. & Barry, M. A. Mol. Ther. Methods Clin. Dev. 33, 101402 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel G. Anderson.

Ethics declarations

Competing interests

H.M. and Y.H. declare no competing interests. D.G.A discloses competing interest due to past and present advising roles for Alnylam, Sanofi, Translate Bio, oRNA Therapeutics, CRISPR Therapeutics, Souffle Therapeutics and Combined Therapeutics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mughal, H., Hu, Y. & Anderson, D.G. Tuning the immune response to mRNA vaccines. Nat Biotechnol (2026). https://doi.org/10.1038/s41587-026-03125-0

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41587-026-03125-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing